Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$498M |
| 2 |
Micron Technology
MU
|
+$374M |
| 3 |
Amazon
AMZN
|
+$356M |
| 4 |
Accenture
ACN
|
+$318M |
| 5 |
Advanced Micro Devices
AMD
|
+$301M |
Top Sells
| 1 |
Apple
AAPL
|
+$684M |
| 2 |
Meta Platforms (Facebook)
META
|
+$630M |
| 3 |
Tesla
TSLA
|
+$595M |
| 4 |
Chevron
CVX
|
+$497M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| 1 | Healthcare | 19.38% |
| 2 | Technology | 18.55% |
| 3 | Consumer Staples | 10.17% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Financials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
1526
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $4.31M | 0.01% |
219,342
-53,620
| -20% | -$1.05M |
|
1527
FIVE9
FIVN
$2.05B
| $4.31M | 0.01% |
+57,500
| New | +$4.31M |
|
|
CNCE
1528
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.31M | 0.01% |
642,605
-285,579
| -31% | -$1.91M |
|
1529
Transmedics
TMDX
$4.13B
| $4.3M | 0.01% |
+102,999
| New | +$4.3M |
|
1530
AtriCure
ATRC
$1.82B
| $4.29M | 0.01% |
109,800
+29,700
| +37% | +$1.16M |
|
|
API
1531
Agora
API
$353M
| $4.28M | 0.01% |
1,179,349
-285,551
| -19% | -$1.04M |
|
1532
Cohu
COHU
$1.09B
| $4.28M | 0.01% |
165,954
+117,600
| +243% | +$3.03M |
|
1533
Puma Biotechnology
PBYI
$228M
| $4.27M | 0.01% |
1,799,662
-177,273
| -9% | -$420K |
|
|
GMRE
1534
Global Medical REIT
GMRE
$517M
| $4.25M | 0.01% |
499,000
-20,700
| -4% | -$176K |
|
1535
ProPhase Labs
PRPH
$17.4M
| $4.25M | 0.01% |
376,810
+126,200
| +50% | +$1.42M |
|
1536
Topgolf Callaway Brands
MODG
$1.75B
| $4.25M | 0.01% |
220,500
+28,300
| +15% | +$545K |
|
1537
Dycom Industries
DY
$7.84B
| $4.24M | 0.01% |
44,400
+23,200
| +109% | +$2.22M |
|
1538
ProShares Short 20+ Year Treasury ETF
TBF
$69.7M
| $4.23M | 0.01% |
189,800
+37,900
| +25% | +$845K |
|
1539
Dole
DOLE
$1.29B
| $4.23M | 0.01% |
579,576
-93,524
| -14% | -$683K |
|
1540
Provident Financial
PROV
$103M
| $4.23M | 0.01% |
297,547
-24,800
| -8% | -$352K |
|
1541
Gorman-Rupp
GRC
$1.17B
| $4.22M | 0.01% |
177,415
+6,100
| +4% | +$145K |
|
1542
Griffon
GFF
$3.57B
| $4.21M | 0.01% |
142,600
+9,600
| +7% | +$283K |
|
1543
Atlanticus Holdings
ATLC
$1.08B
| $4.21M | 0.01% |
160,358
+1,150
| +0.7% | +$30.2K |
|
1544
Technology Select Sector SPDR Fund
XLK
$88.3B
| $4.21M | 0.01% |
35,400
+13,800
| +64% | +$1.64M |
|
1545
8x8 Inc
EGHT
$301M
| $4.18M | 0.01% |
1,212,030
-336,900
| -22% | -$1.16M |
|
1546
Vishay Intertechnology
VSH
$2.14B
| $4.18M | 0.01% |
234,949
+37,224
| +19% | +$662K |
|
1547
Tronox
TROX
$802M
| $4.18M | 0.01% |
+340,900
| New | +$4.18M |
|
1548
Valhi
VHI
$473M
| $4.18M | 0.01% |
165,987
-19,930
| -11% | -$501K |
|
1549
TripAdvisor
TRIP
$2.22B
| $4.17M | 0.01% |
+188,900
| New | +$4.17M |
|
1550
HCI Group
HCI
$2.4B
| $4.16M | 0.01% |
106,019
-28,907
| -21% | -$1.13M |
|